tiprankstipranks
Acelrx Pharmaceuticals (ACRX)
NASDAQ:ACRX

Acelrx (ACRX) Stock News & Sentiment

1,890 Followers
Two option delistings on January 11th
PremiumThe Fly
Two option delistings on January 11th
3M ago
AcelRx changing its name to Talphera
PremiumThe Fly
AcelRx changing its name to Talphera
3M ago
AcelRx changing its name to Talphera
PremiumThe Fly
AcelRx changing its name to Talphera
3M ago
AcelRx files $150M mixed securities shelf
PremiumThe Fly
AcelRx files $150M mixed securities shelf
5M ago
AcelRx Reports Third Quarter 2023 Financial Results and Provides Corporate Update
PremiumPress Releases
AcelRx Reports Third Quarter 2023 Financial Results and Provides Corporate Update
5M ago
Is ACRX a Buy, Before Earnings?
PremiumPre-Earnings
Is ACRX a Buy, Before Earnings?
5M ago
AcelRx receives FDA approval for pivotal study of Niyad
PremiumThe Fly
AcelRx receives FDA approval for pivotal study of Niyad
6M ago
More ACRX News >

News Score - Last 7 Days

Neutral
ACRX
Sector Average
Media Buzz
This Week2 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average63%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ACRX’s Media Buzz Sentiment?
2 articles about ACRX were published this week. In an average week, 1 articles are published.
    What is ACRX’s weekly average amount of articles?
    In an average week, 1 articles about ACRX are published.
      What is ACRX’s News Sentiment?
      50% of articles about ACRX were positive this week, compared to its sector average of 63%.
        Healthcare Stocks that are Trending in the News
        MDWDMediwound
        GRFSGrifols SA
        HALBHalberd
        NVRONevro Corp
        ISRGIntuitive Surgical
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis